• 21Shares has filed a brand new Spot Injective (INJ) ETF with the U.S. Securities and Change Fee.
• The ETF issuer filed its software on October 20, 2025, making Injective considered one of a number of altcoins which have filed a number of ETF functions with the SEC.
• INJ is buying and selling at $8.75 because the cryptocurrency appears set to bounce again from current lows amid a bullish run supported by ETFs.

21Shares, a number one issuer of crypto alternate traded merchandise, has filed a brand new software for a spot alternate traded fund (ETF) with the U.S. Securities and Change Fee.

Injective’s native token INJ value rose barely amidst this growth, with bulls sustaining it above the $8.00 stage.

Share 21 New Injection Spot ETF Recordsdata

Injective’s official X account shared information on Monday that it had filed 21Shares’ INJ ETF with the SEC.

The proposed 21Shares Injective ETF is meant to offer buyers with direct publicity to INJ, based on the submitting.

Following the preliminary launch of spot ETFs for Bitcoin and Ethereum, in addition to different proposed listings, the 21Shares Injective ETF is an exchange-traded fund that chilly storages bodily INJ tokens.

“This can be a massive signal of rising institutional curiosity, making $INJ one of many few digital belongings with a number of ETF merchandise within the works,” the Injective workforce posted on X.

Injective is among the high 100 cryptocurrencies and continues to see progress throughout the business, pushed by areas similar to decentralized finance and real-world belongings.

Not too long ago, the Layer 1 Challenge held its first assembly of the Injection Council.

The platform’s rising presence and adoption has been considerably pushed by business leaders, together with the native Ethereum digital machine, digital asset treasury, INJ ETF, and pre-IPO market, that are serving to advance key strategic roadmap goals.

Key companions embody Google Cloud, T-Cellular, Deutsche Telekom, YZi Labs, Galaxy Digital, and BitGo.

Canary Capital beforehand utilized to turn into an INJ ETF in July.

Injective is a high-performance layer 1 blockchain designed for decentralized monetary providers (DeFi).

The platform can course of over 25,000 transactions per second and leverages its native token, INJ, to safe the community via a delegated proof-of-stake (DPoS) consensus mechanism.

Blockchain addresses infrastructure challenges similar to liquidity fragmentation and gradual transaction finality by integrating alternate primitives with CosmWasm-based composability, and Comet BFT (previously Tendermint BFT) ensures quick finality.

INJ value outlook as ETF approval hype features momentum

As talked about above, INJ traded round $8.75 amid widespread cryptocurrency volatility.

Whereas the token value didn’t explode amid the ETF information, general market enthusiasm has elevated.

The constructive outlook is essentially as a result of expectations that the SEC is anticipated to present the inexperienced mild to a number of crypto ETFs and that the present downward strain available in the market may dissipate and bulls may take over.

Injective’s value has fallen from a excessive of round $35 in December 2024 and is nicely under its all-time excessive of $52.75 in March 2024.

Nonetheless, bulls need the value to maintain above $8.00 after the sharp drop on October 17, 2025, which drops to round $7.80.

Previous to this, INJ had proven resilience, rebounding from April’s lows of $6.90.

Apart from the ETF-driven momentum, bets on authorities bond belongings, such because the $100 million transfer by Pineapple Monetary, are additionally serving to bulls.